These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 31610801)

  • 1. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.
    Chitapanarux I; Klunklin P; Pinitpatcharalert A; Sripan P; Tharavichitkul E; Nobnop W; Onchan W; Chakrabandhu S; Jia-Mahasap B; Euathrongchit J; Wannasopha Y; Srisuwan T
    Radiat Oncol; 2019 Oct; 14(1):175. PubMed ID: 31610801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.
    Wong JS; Uno H; Tramontano AC; Fisher L; Pellegrini CV; Abel GA; Burstein HJ; Chun YS; King TA; Schrag D; Winer E; Bellon JR; Cheney MD; Hardenbergh P; Ho A; Horst KC; Kim JN; Leonard KL; Moran MS; Park CC; Recht A; Soto DE; Shiloh RY; Stinson SF; Snyder KM; Taghian AG; Warren LE; Wright JL; Punglia RS
    JAMA Oncol; 2024 Oct; 10(10):1370-1378. PubMed ID: 39115975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
    Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.
    Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial.
    Khan AJ; Poppe MM; Goyal S; Kokeny KE; Kearney T; Kirstein L; Toppmeyer D; Moore DF; Chen C; Gaffney DK; Haffty BG
    J Clin Oncol; 2017 Jun; 35(18):2037-2043. PubMed ID: 28459606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
    He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
    PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.
    Wang SL; Fang H; Song YW; Wang WH; Hu C; Liu YP; Jin J; Liu XF; Yu ZH; Ren H; Li N; Lu NN; Tang Y; Tang Y; Qi SN; Sun GY; Peng R; Li S; Chen B; Yang Y; Li YX
    Lancet Oncol; 2019 Mar; 20(3):352-360. PubMed ID: 30711522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial.
    Mutter RW; Giri S; Fruth BF; Remmes NB; Boughey JC; Harless CA; Ruddy KJ; McGee LA; Afzal A; Gao RW; Shumway DA; Vern-Gross TZ; Villarraga HR; Kenison SL; Kang Y; Wong WW; Stish BJ; Merrell KW; Yan ES; Park SS; Corbin KS; Vargas CE
    Lancet Oncol; 2023 Oct; 24(10):1083-1093. PubMed ID: 37696281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing hypofractionated to conventional fractionated radiotherapy in postmastectomy breast cancer: a meta-analysis and systematic review.
    Liu L; Yang Y; Guo Q; Ren B; Peng Q; Zou L; Zhu Y; Tian Y
    Radiat Oncol; 2020 Jan; 15(1):17. PubMed ID: 31952507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis on safety and effectiveness of hypofractioned post-mastectomy radiotherapy.
    Bochenek-Cibor J; Georgiew F; Goyal S
    Breast J; 2020 Feb; 26(2):176-181. PubMed ID: 31531930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Hypofractionated Radiotherapy in Postoperative Irradiation for Breast Cancer: An Asian Multi-institutional Prospective Study.
    Okonogi N; Kono S; Karasawa K; Banu PA; Xu X; Erawati D; Adylkhanov T; Jang WI; E Y; Calaguas MJ; Thephamongkhol K; Dung TA; Ng WNP; Kato S;
    Clin Oncol (R Coll Radiol); 2023 Jul; 35(7):463-471. PubMed ID: 37179216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and toxicity following post-operative hypofractionated radiotherapy to the regional nodes and the breast or the chest wall in locally advanced breast cancer.
    Tramacere F; Arcangeli S; Colciago RR; Lucchini R; Pati F; Portaluri M
    Br J Radiol; 2022 Jul; 95(1135):20211299. PubMed ID: 35522785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
    Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
    Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of toxicities and outcomes in patients with breast cancer treated with hypofractionated radiotherapy.
    Sindhu M; Malik M; Ahmed SF; Valiyaveettil D
    Indian J Cancer; 2020; 57(4):423-427. PubMed ID: 33078749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidates for postmastectomy radiotherapy in patients with pT3N0M0 breast cancer.
    Hamamoto Y; Ohsumi S; Aogi K; Takashima S; Shinohara S; Nakajima N; Kataoka M
    Breast Cancer; 2013 Jul; 20(3):218-22. PubMed ID: 22351124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study.
    Leonardi MC; Tomio L; Radice D; Takanen S; Bonzano E; Alessandro M; Ciabattoni A; Ivaldi GB; Bagnardi V; Alessandro O; Francia CM; Fodor C; Miglietta E; Veronesi P; Galimberti VE; Orecchia R; Tagliaferri L; Vidali C; Massaccesi M; Guenzi M; Jereczek-Fossa BA;
    Ann Surg Oncol; 2020 Mar; 27(3):752-762. PubMed ID: 31732946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial.
    Yadav BS; Dahiya D; Kannan P; Goyal S; Laroiya I; Irrinki S; Singh NR; Sharma R
    Trials; 2024 Jan; 25(1):21. PubMed ID: 38167339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions.
    Jiang H; Meng L; Zhang H; Dai X; Zhang Q; Ju Z; Yu W; Ma L
    BMC Cancer; 2021 Dec; 21(1):1284. PubMed ID: 34852776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
    De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.